Evidence map›Paper›PMID 41832357›Full record

ArticleLung2026

Lung Volumes in Tobacco-Exposed Individuals with Preserved Spirometry: An Overlooked Pointer of Respiratory Health?

Charmaine J M Lim, Emiel F M Wouters, Tobias L Mraz, Charles G Irvin, Marie-Kathrin Breyer, Robab Breyer-Kohansal

Abstract read
In one paragraph

Article in Lung, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Charmaine J M Lim *Ludwig Boltzmann Institute for Lung Health, Vienna, Austria. charmaine.helk-lim@leadstudy.at.
Emiel F M Wouters *Ludwig Boltzmann Institute for Lung Health, Vienna, Austria.
Tobias L MrazLudwig Boltzmann Institute for Lung Health, Vienna, Austria.
Charles G IrvinDepartment of Pulmonary and Critical Care Medicine, University of Vermont, Burlington, VT, USA.
Marie-Kathrin BreyerLudwig Boltzmann Institute for Lung Health, Vienna, Austria.
Robab Breyer-KohansalLudwig Boltzmann Institute for Lung Health, Vienna, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeSpirometry, the standard for diagnosing chronic obstructive pulmonary disease, has limited sensitivity for early identification of tobacco-exposed individuals with preserved spirometry (TEPS) at risk for respiratory decline. We aimed to determine whether abnormalities in residual volume to total lung capacity ratio (RV/TLC) and total lung capacity (TLC) identify TEPS at higher risk of subsequent spirometric decline.

methods1986 tobacco-exposed individuals (≥ 25 years, ≥ 10 pack-years) with preserved spirometry (FEV

resultsHigh RV/TLC (≥ upper limit of normal, ULN, z-scores > + 1.645) was present in 6.5% of TEPS, predominantly with normal TLC (87.6%) and associated with greater smoking intensity. Notably, elevated RV/TLC associated with disproportionate declines in FEV1/FVC driven by discordant reductions in FEV

conclusionThese findings underscore the limitations of spirometry alone and advocate for routine lung volume assessment in at-risk smokers.

Indexed as

LungPulmonary Disease, Chronic ObstructiveSmokingSpirometryAdultAgedAustriaDisease ProgressionFemaleForced Expiratory VolumeHumansLung Volume MeasurementsMaleMiddle AgedTotal Lung CapacityVital CapacityFEV1/FVCLung volumesPre-COPDResidual volumeTobacco-exposed preserved spirometryTotal lung capacity

Identifiers

PMID41832357
PMCPMC12988985

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.